Dapagliflozin
Who holds supplier records for Dapagliflozin? 35 organisations hold a current record for Dapagliflozin: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (24), China (8) and Poland (1); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Dapagliflozin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/dapagliflozin
Reading the evidence
- 35 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
24 of the 33 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 21 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Dapagliflozin expires 1 Oct 2041. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (35)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Dapagliflozin. Country is the organisation's recorded country, not necessarily the manufacturing site.
- AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD)IndiaActive DMF 40237, 42486 · latest filing Aug 2025
- MSN Laboratories Private LimitedIndia Company GMP cert on recordActive DMF 43828, 30299 · latest filing Mar 2026
- Zhejiang Jingsheng Pharmaceutical Co., Ltd.ChinaActive DMF 39656, 41471 · latest filing Mar 2025
- Alembic Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 32005 · latest filing Aug 2017
- ALIVUS LIFE SCIENCES LTDIndia Company GMP cert on recordActive DMF 31284 · latest filing Jan 2017
- AMI LIFESCIENCES PRIVATE LTDIndia Company GMP cert on recordActive DMF 38009 · latest filing Feb 2023
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 31841 · latest filing Jul 2017
- AZICO BIOPHORE INDIA PVT LTDIndiaActive DMF 38370 · latest filing May 2023
- Biocon LimitedIndiaActive DMF 31762 · latest filing Jul 2017
- BionpharmaActive DMF 32036 · latest filing Sept 2017
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 30729 · latest filing Dec 2016
- Granules India LimitedIndia Company GMP cert on recordActive DMF 39120 · latest filing Dec 2023
- HARMAN FINOCHEM LTDIndia Company GMP cert on recordActive DMF 32170 · latest filing Nov 2017
- HIKAL LTDIndia Company GMP cert on recordActive DMF 32571 · latest filing Apr 2018
- HONOUR LAB LTDIndia Company GMP cert on recordActive DMF 31235 · latest filing Mar 2017
- Jiangsu Hansoh Pharmaceutical Group Company LimitedChina Company GMP cert on recordActive DMF 32117 · latest filing Nov 2017
- Jiangxi Synergy Pharmaceutical Co., LtdChinaActive DMF 39975 · latest filing Jun 2024
- Laurus Labs LimitedIndia Company GMP cert on recordActive DMF 41822 · latest filing Sept 2025
- LEE PHARMA LTDIndia Company GMP cert on recordActive DMF 36994 · latest filing Jun 2023
- LINHAI TIANYU PHARMACEUTICAL CO LTDChinaActive DMF 41188 · latest filing Jan 2025
- LUPIN MANUFACTURING SOLUTIONS LTDActive DMF 31867 · latest filing Aug 2017
- Macleods Pharmaceuticals Ltd.India Company GMP cert on recordActive DMF 31880 · latest filing Aug 2017
- METROCHEM API PRIVATE LTDIndiaActive DMF 36608 · latest filing Feb 2022
- MICRO LABS LTDIndia Company GMP cert on recordActive DMF 32139 · latest filing Nov 2017
- MOREPEN LABORATORIES LTDIndia Company GMP cert on recordActive DMF 36898 · latest filing Mar 2022
- OPTIMUS DRUGS PRIVATE LTDIndiaActive DMF 37089 · latest filing May 2022
- Porton Pharma Solutions Ltd.ChinaActive DMF 39028 · latest filing Oct 2023
- RAKS PHARMA PVT LTDIndiaActive DMF 31951 · latest filing Aug 2017
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 32084 · latest filing Nov 2017
- USV PRIVATE LTDIndia Company GMP cert on recordActive DMF 36903 · latest filing Sept 2022
- Wisdom Pharmaceutical Co., LtdChinaActive DMF 39006 · latest filing Oct 2023
- Zakłady Farmaceutyczne Polpharma S.A.Poland Company GMP cert on recordActive DMF 30555 · latest filing May 2016
- ZENJI PHARMACEUTICALS (SUZHOU) LTDChinaActive DMF 41913 · latest filing May 2025
- Zhejiang Ausun Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 44605 · latest filing Aug 2026
- Zydus Lifesciences LimitedIndia Company GMP cert on recordActive DMF 31992 · latest filing Aug 2017
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (32 listed products contain Dapagliflozin). The latest listed patent expires 1 Oct 2041. The latest listed exclusivity runs to 12 Dec 2027. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Dapagliflozin is a sodium-glucose cotransporter 2 inhibitor used to manage type 2 diabetes mellitus. It helps improve glycemic control and has cardiovascular benefits.
Chemical identity
- IUPAC name
- (2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
- Canonical SMILES
- CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)Cl
- InChIKey
- JVHXJTBJCFBINQ-ADAARDCZSA-N
- Synonyms
- bms-512148, br1019 component dapagliflozin, dapagliflozin component qternmet, lyn-045, qternmet component dapaglifozin, qternmet xr component dapagliflozin
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Sodium-Glucose Cotransporter 2 Inhibitor
- Mechanism of action
- Sodium-Glucose Transporter 2 Inhibitors
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Dapagliflozin?
35 organisations hold an active US FDA Type II Drug Master File or a CEP for Dapagliflozin: AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD) (India), MSN Laboratories Private Limited (India), Zhejiang Jingsheng Pharmaceutical Co., Ltd. (China), Alembic Pharmaceuticals Limited (India), ALIVUS LIFE SCIENCES LTD (India), AMI LIFESCIENCES PRIVATE LTD (India), APITORIA PHARMA PRIVATE LTD (India) and AZICO BIOPHORE INDIA PVT LTD (India), and 27 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Dapagliflozin Drug Master Files are active?
AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD) (DMF 40237, 42486), MSN Laboratories Private Limited (DMF 43828, 30299), Zhejiang Jingsheng Pharmaceutical Co., Ltd. (DMF 39656, 41471), Alembic Pharmaceuticals Limited (DMF 32005), ALIVUS LIFE SCIENCES LTD (DMF 31284), AMI LIFESCIENCES PRIVATE LTD (DMF 38009), APITORIA PHARMA PRIVATE LTD (DMF 31841) and AZICO BIOPHORE INDIA PVT LTD (DMF 38370) and 27 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
Does the FDA Orange Book list patents for products containing Dapagliflozin?
Yes. The latest patent listed for an approved US product containing Dapagliflozin expires 1 Oct 2041, across 32 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Dapagliflozin supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Dapagliflozin?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.